GEODE CAPITAL MANAGEMENT, LLC

Holdings History for TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

Symbol: TCRX on Nasdaq
Investment type: Equity / Voting Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$562,360	562,153	-5,504	-0.97%	$1.00	Q4 2025
30 Sep 2025	0%	0%	$1,033,532	567,657	+1,286	+0.23%	$1.82	Q3 2025
30 Jun 2025	0%	-0%	$821,529	566,371	-448,719	-44%	$1.45	Q2 2025
31 Mar 2025	0%	+0%	$1,401,161	1,015,090	+51,833		$1.38	Q1 2025
31 Dec 2024	0%	-0%	$2,929,040	963,257	-10,209	-1%	$3.04	Q4 2024
30 Sep 2024	0%	+0%	$4,848,836	973,466	+72,967	+8.1%	$4.98	Q3 2024
30 Jun 2024	0%	+0%	$5,269,115	900,499	+486,720	+118%	$5.85	Q2 2024
31 Mar 2024	0%	+0%	$3,286,207	413,779	+22,133	+5.7%	$7.94	Q1 2024
31 Dec 2023	0%	+0%	$2,283,836	391,646	+83,708	+27%	$5.83	Q4 2023
30 Sep 2023	0%	+0%	$788,582	307,938	+191,047	+163%	$2.56	Q3 2023
30 Jun 2023	0%	+0%	$292,227	116,891	+16,449	+16%	$2.50	Q2 2023
31 Mar 2023	0%	0%	$210,928	100,442	0		$2.10	Q1 2023
31 Dec 2022	0%	0%	$163,000	100,442	-227	-0.23%	$1.62	Q4 2022
30 Sep 2022	0%	+0%	$307,000	100,669	+66,568	+195%	$3.05	Q3 2022
30 Jun 2022	0%	0%	$107,000	34,101	+942	+2.8%	$3.14	Q2 2022
31 Mar 2022	0%	+0%	$92,000	33,159	+7,738	+30%	$2.77	Q1 2022
31 Dec 2021	0%	+0%	$114,000	25,421	+12,635	+99%	$4.48	Q4 2021
30 Sep 2021	0%	+0%	$106,000	12,786	+12,786	NEW	$8.29	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.